New Consortium Members

As of 24th June 2019, Roche Austria GmbH and Roche Diagnostic GmbH have joined the CBmed consortium. Within the second COMET funding period, the new partners will be involved in 2 projects in the field of cancer treatment. Just recently, Roche has launched its NAVIFY Tumor Board solution, enforcing data driven applications within the clinical setting. Together with Roche, CBmed will have the opportunity to build on previous successes of the first funding period, including advancing of natural language processing together with clinical phenotyping and its inhouse FUSION technology with a strong focus on cross-platform data integration.

The COMET Center CBmed is funded within COMET – Competence Centers for Excellent Technologies by the Federal Ministry of Transport, Innovation and Technology (BMVIT), the Federal Ministry for Digital and Economic Affairs (BMDW), Land Steiermark (Styrian Business Promotion Agency – SFG) and Land Wien (Vienna Business Agency – WAW). The COMET program is executed by the Austrian Research Promotion Agency (FFG).

CBmed GmbH Center for Biomarker Research in Medicine
Stiftingtalstrasse 5   8010 Graz   Austria   office@cbmed.at   +43 316 385 28801

PRESS CORNER     CONTACT     IMPRINT     PRIVACY

Font Resize
Contrast